EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

From EBV-Induced Hemophagocytic Lymphohistiocytosis to COVID-19 triggered Sweet Syndrome: A Polyphasic Clinical Journey

Aysal Mahmood iD, Mariana Vanoye Tamez, Freya H Shah, Syeda Sayeed

Journal of Brown Hospital Medicine · 01.07.2026 · 5 (3)

DOI: 10.56305/001c.162038 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Brown Hospital Medicine, online erschienen am 01.07.2026. Verfasst von Aysal Mahmood und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine Landmark Medical Center, New York Medical College. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemophagocytic Lymphohistiocytosis (HLH) and Sweet Syndrome are two hyperinflammatory conditions, which can be genetic or precipitated by infections, primary immunodeficiencies, autoimmune conditions, or certain therapies and transplants. HLH results because of a exaggerated response by the dysregulated CD+ T cells, leading to widespread activation of macrophages, resulting in hemophagocytosis and excessive, organ-damaging inflammation. Sweet syndrome is another uncommon condition, presenting as sudden onset of painful, edematous, and erythematous papules, plaques, or nodules on the skin, precipitated by the same. It is unusual for them to present sequentially, so herein we present a case of two distinct hyperinflammatory syndromes, Epstein Bar Virus-triggered HLH followed by COVID-19 triggered necrotizing Sweet Syndrome, both occurring in a 53-year-old patient with history of remote history of juvenile idiopathic arthritis within a short time span.

Schlagwörter

Stichwörter der Autor:innen

COVID-19EBVEBV induced HLHHLHNecrotizing sweet syndromeSweet syndrome

Autor:innen und Institutionen

  • Department of Internal Medicine Landmark Medical Center, New York Medical College.
  • Division of Rheumatology Boston Medical Center.
  • Division of Rheumatology Landmark Medical Center, New York Medical College.

ORCID-Profile: Aysal Mahmood

Zitieren

APA

Mahmood, A., Vanoye Tamez, M., Shah, F. H., & Sayeed, S. (2026). From EBV-Induced Hemophagocytic Lymphohistiocytosis to COVID-19 triggered Sweet Syndrome: A Polyphasic Clinical Journey. Journal of Brown Hospital Medicine, 5(3). https://doi.org/10.56305/001c.162038

Vancouver

Mahmood A, Vanoye Tamez M, Shah FH, Sayeed S. From EBV-Induced Hemophagocytic Lymphohistiocytosis to COVID-19 triggered Sweet Syndrome: A Polyphasic Clinical Journey. Journal of Brown Hospital Medicine. 2026;5(3). doi:10.56305/001c.162038

BibTeX
@article{Mahmood2026,
  author = {Mahmood, Aysal and Vanoye Tamez, Mariana and Shah, Freya H and Sayeed, Syeda},
  title = {From EBV-Induced Hemophagocytic Lymphohistiocytosis to COVID-19 triggered Sweet Syndrome: A Polyphasic Clinical Journey},
  journal = {Journal of Brown Hospital Medicine},
  year = {2026},
  volume = {5},
  number = {3},
  doi = {10.56305/001c.162038}
}
Kostenlos starten →